
William G. Wright
Examiner (ID: 13821)
| Most Active Art Unit | 1106 |
| Art Unit(s) | 1106, 1754 |
| Total Applications | 637 |
| Issued Applications | 554 |
| Pending Applications | 0 |
| Abandoned Applications | 83 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10241556
[patent_doc_number] => 20150126551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'USE OF A HYDROXIMIC ACID HALIDE DERIVATIVE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/594817
[patent_app_country] => US
[patent_app_date] => 2015-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4474
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14594817
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/594817 | USE OF A HYDROXIMIC ACID HALIDE DERIVATIVE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | Jan 11, 2015 | |
Array
(
[id] => 10289111
[patent_doc_number] => 20150174109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'BERBERINE FORMULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/576476
[patent_app_country] => US
[patent_app_date] => 2014-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5370
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14576476
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/576476 | Berberine formulations and uses thereof | Dec 18, 2014 | Issued |
Array
(
[id] => 10220423
[patent_doc_number] => 20150105416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'TREATING POSTOPERATIVE NAUSEA AND VOMITING'
[patent_app_type] => utility
[patent_app_number] => 14/574858
[patent_app_country] => US
[patent_app_date] => 2014-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5479
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14574858
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/574858 | TREATING POSTOPERATIVE NAUSEA AND VOMITING | Dec 17, 2014 | Abandoned |
Array
(
[id] => 10297527
[patent_doc_number] => 20150182527
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-02
[patent_title] => 'COMPOSITIONS, DEVICES AND METHODS OF TREATING INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/572057
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6024
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14572057
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/572057 | COMPOSITIONS, DEVICES AND METHODS OF TREATING INFECTIONS | Dec 15, 2014 | Abandoned |
Array
(
[id] => 10311576
[patent_doc_number] => 20150196578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/566354
[patent_app_country] => US
[patent_app_date] => 2014-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6786
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14566354
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/566354 | COMBINATION THERAPY TREATMENT FOR VIRAL INFECTIONS | Dec 9, 2014 | Abandoned |
Array
(
[id] => 10209309
[patent_doc_number] => 20150094299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'PURINONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/564568
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25075
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/564568 | Purinone derivative | Dec 8, 2014 | Issued |
Array
(
[id] => 10209309
[patent_doc_number] => 20150094299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'PURINONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/564568
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25075
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/564568 | Purinone derivative | Dec 8, 2014 | Issued |
Array
(
[id] => 10209309
[patent_doc_number] => 20150094299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'PURINONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/564568
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25075
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/564568 | Purinone derivative | Dec 8, 2014 | Issued |
Array
(
[id] => 10209309
[patent_doc_number] => 20150094299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'PURINONE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 14/564568
[patent_app_country] => US
[patent_app_date] => 2014-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25075
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564568
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/564568 | Purinone derivative | Dec 8, 2014 | Issued |
Array
(
[id] => 10209333
[patent_doc_number] => 20150094323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'METHODS OF TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/563537
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22133
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14563537
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/563537 | Methods of treating and/or preventing cardiovascular disease | Dec 7, 2014 | Issued |
Array
(
[id] => 10209332
[patent_doc_number] => 20150094322
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'SUSTAINED-RELEASE FORMULATIONS OF COLCHICINE AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/563503
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22176
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14563503
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/563503 | Sustained-release formulations of colchicine and methods of using same | Dec 7, 2014 | Issued |
Array
(
[id] => 10209293
[patent_doc_number] => 20150094282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-02
[patent_title] => 'TETRACYCLINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/562449
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 20009
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14562449
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/562449 | Tetracycline compositions | Dec 4, 2014 | Issued |
Array
(
[id] => 10272570
[patent_doc_number] => 20150157568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'Treatment of Spasticity with Intrathecal Dantrolene'
[patent_app_type] => utility
[patent_app_number] => 14/560662
[patent_app_country] => US
[patent_app_date] => 2014-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2025
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14560662
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/560662 | Treatment of Spasticity with Intrathecal Dantrolene | Dec 3, 2014 | Abandoned |
Array
(
[id] => 10262389
[patent_doc_number] => 20150147386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/559598
[patent_app_country] => US
[patent_app_date] => 2014-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12491
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14559598
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/559598 | EGFR antagonist for the treatment of heart disease | Dec 2, 2014 | Issued |
Array
(
[id] => 11098890
[patent_doc_number] => 20160295861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-13
[patent_title] => 'COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES'
[patent_app_type] => utility
[patent_app_number] => 15/037553
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2377
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15037553
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/037553 | Compositions of dibromomalonamide and their use as biocides | Nov 23, 2014 | Issued |
Array
(
[id] => 10263386
[patent_doc_number] => 20150148383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'Methods for Inhibiting or Reversing Epiretinal Membrane Formation'
[patent_app_type] => utility
[patent_app_number] => 14/550304
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12133
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14550304
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/550304 | Methods for Inhibiting or Reversing Epiretinal Membrane Formation | Nov 20, 2014 | Abandoned |
Array
(
[id] => 10256521
[patent_doc_number] => 20150141518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'WATER-MISCIBLE STABLE SOLUTION COMPOSITION FOR PHARMACEUTICALLY ACTIVE INGREDIENTS THAT ARE POORLY SOLUBLE IN WATER AND SUSCEPTIBLE TO CHEMICAL DEGRADATION'
[patent_app_type] => utility
[patent_app_number] => 14/550041
[patent_app_country] => US
[patent_app_date] => 2014-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3304
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14550041
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/550041 | WATER-MISCIBLE STABLE SOLUTION COMPOSITION FOR PHARMACEUTICALLY ACTIVE INGREDIENTS THAT ARE POORLY SOLUBLE IN WATER AND SUSCEPTIBLE TO CHEMICAL DEGRADATION | Nov 20, 2014 | Abandoned |
Array
(
[id] => 10263361
[patent_doc_number] => 20150148358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-28
[patent_title] => 'NOVEL DGAT2 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/547615
[patent_app_country] => US
[patent_app_date] => 2014-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7801
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14547615
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/547615 | DGAT2 inhibitors | Nov 18, 2014 | Issued |
Array
(
[id] => 10226858
[patent_doc_number] => 20150111852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => '1-Di(sec-butyl)-phosphinoyl-pentane (dapa-2-5) as a topical agent...'
[patent_app_type] => utility
[patent_app_number] => 14/544042
[patent_app_country] => US
[patent_app_date] => 2014-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27296
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14544042
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/544042 | 1-Di(sec-butyl)-phosphinoyl-pentane (dapa-2-5) as a topical agent... | Nov 17, 2014 | Abandoned |
Array
(
[id] => 14029439
[patent_doc_number] => 10226450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-12
[patent_title] => Pharmaceutical film composition
[patent_app_type] => utility
[patent_app_number] => 15/512575
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6069
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15512575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/512575 | Pharmaceutical film composition | Nov 6, 2014 | Issued |